LWA
COCH icon

Lantern Wealth Advisors’s Envoy Medical COCH Stock Holding History

Lantern Wealth Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,000
Closed -$20K – 186
2026
Q1 		$20K Buy
+30,000
New +$20.5K 0.01% 174

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Lantern Wealth Advisors's COCH Position: Q2 2026 in Review

Lantern Wealth Advisors sold out of Envoy Medical (COCH) in Q2 2026, closing a stake of 30,000 shares — an estimated $20K sold.

Lantern Wealth Advisors first reported a position in COCH in Q1 2026 and held it in 1 quarter. The position peaked at $20K in Q1 2026. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Lantern Wealth Advisors reported no remaining Envoy Medical position as of Q2 2026 after selling out during the quarter.
  • Lantern Wealth Advisors sold 30,000 Envoy Medical shares in Q2 2026, an estimated $20K.
  • Lantern Wealth Advisors first reported a position in Envoy Medical in Q1 2026 and held it in 1 quarter.
  • Lantern Wealth Advisors's Envoy Medical position peaked at $20K in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Lantern Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.